Erratum: Interventions to delay functional decline in people with dementia: A systematic review of systematic reviews (BMJ Open (2016) 6 (e010767) DOI: 10.1136/bmjopen-2015-010767);Interventions to delay functional decline in people with dementia: A systematic review of systematic reviews

BMJ Open

Volumn 6, Issue 4, 2016, Pages

  Laver, Kate ^a   Dyer, Suzanne ^a   Whitehead, Craig ^a   Clemson, Lindy ^b   Crotty, Maria ^a  

^a FLINDERS UNIVERSITY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE INHIBITOR; DIMEBON; DONEPEZIL; HERBACEOUS AGENT; HUPERZINE A; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MELATONIN; MEMANTINE; NIMODIPINE; PHOSPHATIDYLCHOLINE; RIVASTIGMINE; SELEGILINE; DOPAMINE RECEPTOR STIMULATING AGENT;

ACTIVITY OF DAILY LIVING ASSESSMENT; AROMATHERAPY; ARTICLE; BARTHEL INDEX; DEMENTIA; EXERCISE; GINKGO BILOBA; HUMAN; PHOTOTHERAPY; SYSTEMATIC REVIEW; ALTERNATIVE MEDICINE; ALZHEIMER DISEASE; CAREGIVER; DAILY LIFE ACTIVITY; QUALITY OF LIFE;

ACTIVITIES OF DAILY LIVING; ALZHEIMER DISEASE; CAREGIVERS; CHOLINESTERASE INHIBITORS; COMPLEMENTARY THERAPIES; DEMENTIA; DOPAMINE AGENTS; EXERCISE; HUMANS; MEMANTINE; QUALITY OF LIFE;

EID: 84970977766     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2015-010767corr1     Document Type: Erratum

References (56)

1. Prince M, Bryce R, Albanese E, et al. The global prevalence of dementia: A systematic review and metaanalysis. Alzheimers Dement 2013;9:63-75e2.
2. Prince M, Guerchet M, Prina M, et al. Policy briefs for heads of government: The global impact of dementia 2013-2050. London: Alzheimer's Disease International 2013.
3. Andersen CK, Wittrup-Jensen KU, Lolk A, et al. Ability to perform activities of daily living is the main factor affecting quality of life in patients with dementia. Health Qual Life Outcomes 2004;2:52.
4. Gustavsson A, Brinck P, Bergvall N, et al. Predictors of costs of care in Alzheimer's disease: A multinational sample of 1222 patients. Alzheimers Dement 2011;7:318-27.
5. Brodaty H, Woodward M, Boundy K, et al. Prevalence and predictors of burden in caregivers of people with dementia. Am J Geriatr Psychiatry 2014;22:756-65.
6. Brodaty H, Seeher K, Gibson L. Dementia time to death: A systematic literature review on survival time and years of life lost in people with dementia. Int Psychogeriatr 2012;24:1034-45.
7. Kurrle S, Brodaty H, Hogarth R. Physical co morbidities of dementia. Cambridge University Press, 2012.
8. Alzheimer's Australia. Report for the Department of Health and Ageing in relation to services for Consumer Engagement in the Aged Care Reform Process. Canberra, 2011.
9. Higgins J, Green S. Cochrane handbook for systematic reviews of interventions version 5.1. 0 [updated March 2011]. The Cochrane Collaboration, 2011.
10. NHS Centre for Reviews and Dissemination. Undertaking systematic reviews of research on effectiveness. CRD's guidance for those carrying out or commissioning reviews. 2nd edn. Centre for Reviews and Dissemination, 2001.
11. Shea BJ, Grimshaw JM, Wells GA, et al. Development of AMSTAR: A measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol 2007;7:10.
12. Guyatt GH, Oxman AD, Vist GE, et al. GRADE: An emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336:924-6.
13. Bahar-Fuchs A, Clare L, Woods B. Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer's disease and vascular dementia. Cochrane Database Syst Rev 2013;6:CD003260.
14. Chau S, Herrmann N, Ruthirakuhan MT, et al. Latrepirdine for Alzheimer's disease. Cochrane Database Syst Rev 2015;4: CD009524.
15. Forbes D, Blake CM, Thiessen EJ, et al. Light therapy for improving cognition, activities of daily living, sleep, challenging behaviour, and psychiatric disturbances in dementia. Cochrane Database Syst Rev 2014;2:CD003946.
16. Forbes D, Thiessen EJ, Blake CM, et al. Exercise programs for people with dementia. Cochrane Database Syst Rev 2013;12: CD006489.
17. Forrester LT, Maayan N, Orrell M, et al. Aromatherapy for dementia. Cochrane Database Syst Rev 2014;2:CD003150.
18. Jansen SL, Forbes DA, Duncan V, et al. Melatonin for cognitive impairment. Cochrane Database Syst Rev 2006;(1):CD003802.
19. Lee MS, Shin BC, Ernst E. Acupuncture for Alzheimer's disease: A systematic review. Int J Clin Pract 2009;63:874-9.
20. Li M-M, Yu J-T, Wang H-F, et al. Efficacy of vitamins B supplementation on mild cognitive impairment and Alzheimer's disease: A systematic review and meta-analysis. Curr Alzheimer Res 2014;11:844-52.
21. Liu W, Cheon J, Thomas SA. Interventions on mealtime difficulties in older adults with dementia: A systematic review. Int J Nurs Stud 2014;51:14-27.
22. McCleery J, Cohen DA, Sharpley AL. Pharmacotherapies for sleep disturbances in Alzheimer's disease. Cochrane Database Syst Rev 2014;3:CD009178.
23. McGuinness B, Craig D, Bullock R, et al. Statins for the treatment of dementia. Cochrane Database Syst Rev 2014;7:CD007514.
24. Neal M, Barton Wright P. Validation therapy for dementia. Cochrane Database Syst Rev 2009;(3):CD001394.
25. Orgeta V, Qazi A, Spector AE, et al. Psychological treatments for depression and anxiety in dementia and mild cognitive impairment. Cochrane Database Syst Rev 2014;1:CD009125.
26. Reilly S, Miranda-Castillo C, Malouf R, et al. Case management approaches to home support for people with dementia. Cochrane Database Syst Rev 2015;1:CD008345.
27. Tan C-C, Yu J-T, Wang H-F, et al. Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer's disease: A systematic review and meta-analysis. J Alzheimers Dis 2014;41:615-31.
28. Tan MS, Yu JT, Tan CC, et al. Efficacy and adverse effects of Ginkgo biloba for cognitive impairment and dementia: A systematic review and meta-analysis. J Alzheimers Dis 2015;43:589-603.
29. Ueda T, Suzukamo Y, Sato M, et al. Effects of music therapy on behavioral and psychological symptoms of dementia: A systematic review and meta-analysis. Ageing Res Rev 2013;12:628-41.
30. Van't Leven N, Prick AEJ, Groenewoud JG, et al. Dyadic interventions for community-dwelling people with dementia and their family caregivers: A systematic review. Int Psychogeriatr 2013;25:1581-603.
31. Woods B, Aguirre E, Spector AE, et al. Cognitive stimulation to improve cognitive functioning in people with dementia. Cochrane Database Syst Rev 2012;2:CD005562.
32. Yang G, Wang Y, Tian J, et al. Huperzine A for Alzheimer's disease: A systematic review and meta-analysis of randomized clinical trials. PLoS ONE 2013;8:e74916.
33. Birks J, Flicker L. Selegiline for Alzheimer's disease. Cochrane Database Syst Rev 2003;(1):CD000442.
34. Birks J, Lopez-Arrieta JM. Nimodipine for primary degenerative, mixed and vascular dementia. Cochrane Database Syst Rev 2002; (3):CD000147.
35. Higgins JP, Flicker L. Lecithin for dementia and cognitive impairment. Cochrane Database Syst Rev 2003;(3):CD001015.
36. Bemelmans R, Gelderblom GJ, Jonker P, et al. Socially assistive robots in elderly care: A systematic review into effects and effectiveness. J Am Med Dir Assoc 2012;13:114-20e1.
37. Bernabei V, De Ronchi D, La Ferla T, et al. Animal-assisted interventions for elderly patients affected by dementia or psychiatric disorders: A review. J Psychiatr Res 2013;47:762-73.
38. Cameron M, Lonergan E, Lee H. Transcutaneous electrical nerve stimulation (TENS) for dementia. Cochrane Database Syst Rev 2003;(3):CD004032.
39. Leung P, Orrell M, Orgeta V. Social support group interventions in people with dementia and mild cognitive impairment: A systematic review of the literature. Int J Geriatr Psychiatry 2015;30:1-9.
40. Lu D, Song H, Hao Z, et al. Naftidrofuryl for dementia. Cochrane Database Syst Rev 2011;(12):CD002955.
41. Maayan N, Soares-Weiser K, Lee H. Respite care for people with dementia and their carers. Cochrane Database Syst Rev 2014;1: CD004396.
42. Martin S, Kelly G, Kernohan WG, et al. Smart home technologies for health and social care support. Cochrane Database Syst Rev 2008; (4):CD006412.
43. Sampson EL, Jenagaratnam L, McShane R. Metal protein attenuating compounds for the treatment of Alzheimer's dementia. Cochrane Database Syst Rev 2014;2:CD005380.
44. Tabet N, Feldmand H. Ibuprofen for Alzheimer's disease. Cochrane Database Syst Rev 2003;(2):CD004031.
45. Thompson CA, Spilsbury K, Hall J, et al. Systematic review of information and support interventions for caregivers of people with dementia. BMC Geriatr 2007;7:18.
46. Lopez-Arrieta JM, Schneider L. Metrifonate for Alzheimer's disease. Cochrane Database Syst Rev 2006;(2):CD003155.
47. Hopper T, Bourgeois M, Pimentel J, et al. An evidence-based systematic review on cognitive interventions for individuals with dementia. Am J Speech Lang Pathol 2013;22:126-45.
48. Carrion C, Aymerich M, Bailles E, et al. Cognitive psychosocial intervention in dementia: A systematic review. Dement Geriatr Cogn Disord 2013;36:363-75.
49. Zhu XC, Yu Y, Wang HF, et al. Physiotherapy intervention in Alzheimer's disease: systematic review and meta-analysis. J Alzheimers Dis 2015;44:163-74.
50. Rao AK, Chou A, Bursley B, et al. Systematic review of the effects of exercise on activities of daily living in people with Alzheimer's disease. Am J Occup Ther 2014;68:50-6.
51. Cohen J. Statistical power analysis for the behavioral sciences. Lawrence Erlbaum Associates, Inc. 1977.
52. Cooper C, Mukadam N, Katona C, et al. Systematic review of the effectiveness of non-pharmacological interventions to improve quality of life of people with dementia. Int Psychogeriatr 2012;24:856-70.
53. Cooper C, Mukadam N, Katona C, et al. Systematic review of the effectiveness of pharmacologic interventions to improve quality of life and well-being in people with dementia. Am J Geriatr Psychiatry 2013;21:173-83.
54. Killin LO, Russ TC, Starr JM, et al. The effect of funding sources on donepezil randomised controlled trial outcome: A meta-analysis. BMJ Open 2014;4:e004083.
55. Centre for Health Economics Monash University, University of South Australia Veterans' Medicines Advice and Therapeutics Education Services. Post Market Review Pharmaceutical Benefits Scheme anti-dementia medicines to treat Alzheimer's Disease. 2012. http://www.pbs.gov.au/reviews/anti-dementia-drugs-files/antidementia-report-summary.pdf.
56. Knapp M, Iemmi V, Romeo R. Dementia care costs and outcomes: A systematic review. Int J Geriatr Psychiatry 2013;28:551-61.